Vofatamab (Anti-FGFR3 / CD333)
Product Specifications
CAS Number
1312305-12-6
Synonyms
B-701; MFGR-1877S; RG-7444
Target
FGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Vofatamab (Anti-FGFR3 / CD333) is a monoclonal antibody targeting FGFR3. Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) . MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472173-500 1x 500 µL
Catenin, beta (CTNNB1) (rCTNNB1/2173), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472598-500 1x 500 µL
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681422-100 1x 100 µL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details